BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,367.60
      0.51%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.675
      0.31%
      Bitcoin
      93,235.20
      1.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Genfit (GNFT) Quote

      Genfit

      Genfit (GNFT)

      Genfit SA
      3.98
      0.00
      (0.00%)
      Closed November 27 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.98
      Bid
      3.95
      Ask
      4.14
      Volume
      0.00
      0.00 Day's Range 0.00
      2.90 52 Week Range 5.86
      Market Cap
      198.343M
      Previous Close
      3.98
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      334,111
      Shares Outstanding
      49,834,983
      Dividend Yield
      -
      PE Ratio
      -6.86
      Earnings Per Share (EPS)
      -0.58
      Revenue
      38.68M
      Net Profit
      -28.89M

      About Genfit

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.genfit.com
      Headquarters
      Loos, Nord, Fra
      Founded
      -
      Genfit is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNFT. The last closing price for Genfit was 3.98 €. Over the last year, Genfit shares have traded in a share price range of 2.90 € to 5.86 €.

      Genfit currently has 49,834,983 shares outstanding. The market capitalization of Genfit is 198.34 € million. Genfit has a price to earnings ratio (PE ratio) of -6.86.

      Ask ADVFN Intelligence (AI)

      GNFT Latest News

      More News

      FeaturedCannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer

      17 hours ago

      FeaturedBioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL. Bioquest Corp. and BotMakers, Inc. are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

      18 hours ago

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

      November 13 2024
      UK Regulatory

      GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

      GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

      November 13 2024
      UK Regulatory

      GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

      PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

      November 13 2024
      GlobeNewswire Inc.

      GENFIT : Information financière du troisième trimestre 2024

      GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

      November 07 2024
      UK Regulatory

      GENFIT Reports Third Quarter 2024 Financial Information

      GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

      November 07 2024
      UK Regulatory

      GENFIT Reports Third Quarter 2024 Financial Information

      Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

      November 07 2024
      GlobeNewswire Inc.

      GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

      GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

      September 23 2024
      UK Regulatory

      GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

      Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

      September 23 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.17-4.096385542174.154.223.9451894244.02750881DE
      4-1.25-23.90057361385.235.633.9453015354.71998141DE
      120.328.743169398913.665.863.6253341114.87885979DE
      26-0.22-5.23809523814.25.863.473292424.61093218DE
      520.9832.666666666735.862.92666674.20211652DE
      156133.55704697992.985.862.7462149673.94352117DE
      260-10.63-72.75838466814.6120.962.7463075815.55735792DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ABEOABEO SA
      9.76 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.81 €
      (0.00%)
      		0
      ABAb Science
      0.775 €
      (0.00%)
      		0
      AALBAalberts NV
      33.90 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      3.90 €
      (0.00%)
      		0
      ABEOABEO SA
      9.76 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.81 €
      (0.00%)
      		0
      ABAb Science
      0.775 €
      (0.00%)
      		0
      AALBAalberts NV
      33.90 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      3.90 €
      (0.00%)
      		0
      ABEOABEO SA
      9.76 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.81 €
      (0.00%)
      		0
      ABAb Science
      0.775 €
      (0.00%)
      		0
      AALBAalberts NV
      33.90 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      3.90 €
      (0.00%)
      		0

      Discussion

      View Full Feed
      dinogreeves dinogreeves 3 minutes ago
      Very sad how people got robbed on this, grant it, only 660,000 volume, but is fair to say 300,000 shares got robbed and now some people are going to take a tax loss before the year is up. I wonder who was behind this move, company or frontloaders? They hyped it because of the low float, wow, just
      TGLO
      skitahoe skitahoe 4 minutes ago
      I know this article was posted here, but I'd like to do it again and recommend the moderators consider stickying the article.

      https://www.barchart.com/story/news/29772004/cancer-vaccines-market-forecasted-to-surge-in-coming-years-20242034-analysis-by-delveinsight-dendreon-pharma-cande
      NWBO
      littlejohn littlejohn 6 minutes ago
      Canada got their pipeline to west coast completed

      and is shipping more oil overseas

      from there in 2024...

      They may not want to get dragged thru

      more Keystone flip flops...

      More rich going to D.C. don't care about
      skitahoe skitahoe 8 minutes ago
      The question in my mind is how long can they go without communicating with shareholders, and not be in trouble with the authorities. I know the OTC and Pinks are the Wild West of stock investment, and I have seen companies rise from the dead after years of not reporting, but I believe it cost them
      CRTG
      dinogreeves dinogreeves 9 minutes ago
      They know they financially a strong company, they know they are massively cash flow position, more importantly, they know their business model is largely scalable, why else would they pay off their loans. Let's get the facts straight, this is not share selling scheme, this company is fundamentally
      SMCI
      lovethatgreen lovethatgreen 11 minutes ago
      Up another billion wow

      This is a waste of time
      RDAR
      dinogreeves dinogreeves 14 minutes ago
      Late in the move, suggesting with the filings, SMCI is going make Hindenburg go bankrupt for trying to run their name through the mud. Big time redemption. Watch for press release tomorrow for the reason to payoff the notes is for financial flexibility. The only thing I want to know, how much mor
      SMCI
      XenaLives XenaLives 17 minutes ago
      B.S. and malfeasance liike this is the simplest expolanation for the heath crisis in this country.

      $$$$ are much more important than quality of life or life expectancy of patients....

      https://www.biospace.com/drug-development/mercks-former-asthma-blockbuster-singula
      Brooge warrants cancelled Brooge warrants cancelled 21 minutes ago
      maybe we dipped cause it says blockbuster public offering?
      which stomp has been saying for years
      FNMA
      lodas lodas 23 minutes ago
      Pursuant to the Global Settlement Agreement, and as more fully set forth therein (a) JPMC or its designee will be deemed to be the sole legal, equitable and beneficial owner of the Trust Preferred Securities, (b) the WMI Entities will be deemed to have sold, transferred, and assigned any and all rig
      COOP
      236T568 236T568 27 minutes ago
      Whoaaaaa. Potential great news 

      https://x.com/SpencerGuard/status/1861662030723232225?s=19
      knrorrel knrorrel 28 minutes ago
      question and thanks for the answer.
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175447011
      nowwhat2 nowwhat2 28 minutes ago
      Just to reiterate

      https://investorshub.advfn.com/uimage/uploads/2024/11/27/lwlnhBTC_111111_26_CAPT_1030pm_IMPORT_UTMOST.jpg

      93,413





      https://investorshub.advfn.com/uimage/uploads/2024/11/26/tj[[ebtc_111111_26_30d_833pm_CHAN_
      BTCUSD
      knrorrel knrorrel 29 minutes ago
      question and thanks for the answer.
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175447011
      knrorrel knrorrel 30 minutes ago
      Are there any opinions: "Is the Quantum Hype over or is this the usual breather of a few days before it continues to rise?" ...... I'm itching to buy $QBTS and $QSI back now. After the two-day decline, both stocks have fantastic catalyst patents and should have a great future..... what do you think?
      QBTS QSI
      knrorrel knrorrel 32 minutes ago
      Are there any opinions: "Is the Quantum Hype over or is this the usual breather of a few days before it continues to rise?" ...... I'm itching to buy $QBTS and $QSI back now. After the two-day decline, both stocks have fantastic catalyst patents and should have a great future..... what do you think?
      QBTS QSI
      Zorax Zorax 32 minutes ago
      and the Congress may by law provide for the case wherein neither a President elect nor a Vice President elect shall have qualified, declaring who shall then act as PresidentWhy not the candidate's opponent? The runner up Harris?
      dinogreeves dinogreeves 33 minutes ago
      Analyst are going to digest this 8K tomorrow and depending on what they read into it and how they pick it apart or they already knew? like you said, "So we watch". Wasn't there loan extension a week ago, then abruptly decided to pay them off. Something is going on behind the scenes.
      SMCI
      jay_tee jay_tee 33 minutes ago
      How am I the worst person to respond to anything? lol I guess Maryland should just blindly listen to only the thoughts of folks crossing their fingers hoping and wishing ...Seamus does right by us all... I mean it's 10 yrs so it's way past due. 
      RNVA
      mascale mascale 36 minutes ago
      Actual message board subject, versus posted, noted low literacy levels. (Nestle is OTC, e.g.) "Hiru audit has been in process for several weeks, including financials and re-audit of assets. Hiru is not yet a complex conglomerate so timelines measured in days and weeks are applicable. Most recently.
      HIRU

      Your Recent History

      EU
      GNFT
      Genfit
      Delayed Upgrade Clock